BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 20610816)

  • 1. Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis.
    Yokoyama T; Kanno Y; Yamazaki Y; Takahara T; Miyata S; Nakamura T
    Blood; 2010 Oct; 116(15):2768-75. PubMed ID: 20610816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Trib1 in myeloid leukaemogenesis and differentiation.
    Nakamura T
    Biochem Soc Trans; 2015 Oct; 43(5):1104-7. PubMed ID: 26517931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trib1 promotes acute myeloid leukemia progression by modulating the transcriptional programs of Hoxa9.
    Yoshino S; Yokoyama T; Sunami Y; Takahara T; Nakamura A; Yamazaki Y; Tsutsumi S; Aburatani H; Nakamura T
    Blood; 2021 Jan; 137(1):75-88. PubMed ID: 32730594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.
    Jin G; Yamazaki Y; Takuwa M; Takahara T; Kaneko K; Kuwata T; Miyata S; Nakamura T
    Blood; 2007 May; 109(9):3998-4005. PubMed ID: 17227832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia.
    Yokoyama T; Toki T; Aoki Y; Kanezaki R; Park MJ; Kanno Y; Takahara T; Yamazaki Y; Ito E; Hayashi Y; Nakamura T
    Blood; 2012 Mar; 119(11):2608-11. PubMed ID: 22294728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Mechanism of CCAAT-Enhancer Binding Protein Recruitment by the TRIB1 Pseudokinase.
    Murphy JM; Nakatani Y; Jamieson SA; Dai W; Lucet IS; Mace PD
    Structure; 2015 Nov; 23(11):2111-21. PubMed ID: 26455797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1.
    Yoshida A; Kato JY; Nakamae I; Yoneda-Kato N
    Blood; 2013 Sep; 122(10):1750-60. PubMed ID: 23884858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia.
    Dedhia PH; Keeshan K; Uljon S; Xu L; Vega ME; Shestova O; Zaks-Zilberman M; Romany C; Blacklow SC; Pear WS
    Blood; 2010 Aug; 116(8):1321-8. PubMed ID: 20410507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages.
    Satoh T; Kidoya H; Naito H; Yamamoto M; Takemura N; Nakagawa K; Yoshioka Y; Morii E; Takakura N; Takeuchi O; Akira S
    Nature; 2013 Mar; 495(7442):524-8. PubMed ID: 23515163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
    Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
    Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tribbles in disease: Signaling pathways important for cellular function and neoplastic transformation.
    Yokoyama T; Nakamura T
    Cancer Sci; 2011 Jun; 102(6):1115-22. PubMed ID: 21338441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage migration is controlled by Tribbles 1 through the interaction between C/EBPβ and TNF-α.
    Liu YH; Tan KA; Morrison IW; Lamb JR; Argyle DJ
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):67-75. PubMed ID: 23810419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
    Wang GG; Pasillas MP; Kamps MP
    Blood; 2005 Jul; 106(1):254-64. PubMed ID: 15755900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.
    Garcia-Cuellar MP; Steger J; Füller E; Hetzner K; Slany RK
    Haematologica; 2015 Jul; 100(7):905-13. PubMed ID: 25911551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis.
    Collins C; Wang J; Miao H; Bronstein J; Nawer H; Xu T; Figueroa M; Muntean AG; Hess JL
    Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9899-904. PubMed ID: 24958854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.
    Schnabel CA; Jacobs Y; Cleary ML
    Oncogene; 2000 Feb; 19(5):608-16. PubMed ID: 10698505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.
    Bisaillon R; Wilhelm BT; Krosl J; Sauvageau G
    Blood; 2011 Oct; 118(17):4682-9. PubMed ID: 21900201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CCL9/MIP-1gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells.
    Iotti G; Ferrari-Amorotti G; Rosafio C; Corradini F; Lidonnici MR; Ronchetti M; Bardini M; Zhang Y; Martinez R; Blasi F; Calabretta B
    Oncogene; 2007 May; 26(24):3482-91. PubMed ID: 17160016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRIB1 downregulates hepatic lipogenesis and glycogenesis via multiple molecular interactions.
    Ishizuka Y; Nakayama K; Ogawa A; Makishima S; Boonvisut S; Hirao A; Iwasaki Y; Yada T; Yanagisawa Y; Miyashita H; Takahashi M; Iwamoto S;
    J Mol Endocrinol; 2014 Apr; 52(2):145-58. PubMed ID: 24389359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.